𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta

✍ Scribed by Demetris Delos; Xu Yang; Benjamin F. Ricciardi; Elizabeth R. Myers; Mathias P.G. Bostrom; Nancy Pleshko Camacho


Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
387 KB
Volume
26
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RANKL inhibition, on bone healing and bone strength in the growing oim/oim mouse, a model of moderate to severe OI. Mice [73 oim/oim and 69 wild‐type (WT)] were injected twice weekly with either soluble murine RANK (RANK‐Fc) (1.5 mg/kg) or saline beginning at 6 weeks of age. At 8 weeks of age, the animals underwent transverse mid‐diaphyseal osteotomies of the right femur. Therapy was continued until sacrifice at 2, 3, 4, or 6 weeks postfracture. At 6 weeks post‐fracture, greater callus area (6.59 ± 3.78 mm^2^ vs. 2.67 ± 2.05 mm^2^, p = 0.003) and increased radiographic intensity (mineral density) (0.48 ± 0.14 vs. 0.30 ± 0.80, p = 0.005) were found in the RANK‐Fc versus saline oim/oim group, indicating a delay in callus remodeling. Despite this delay, mechanical tests at 6 weeks postfracture revealed no significant differences in whole bone properties of stiffness and failure moment. Further, RANKL inhibition resulted in a greater failure moment and greater work to failure for the nonfractured contralateral WT bones compared to the nonfractured saline WT bones. Together, these results demonstrate that RANKL inhibition does not adversely affect the mechanical properties of healing bone in the oim/oim mice, and is associated with increased strength in intact bone in the WT mice. Β© 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:153–164, 2008


πŸ“œ SIMILAR VOLUMES


Long-term effects of saw osteotomy versu
✍ Clemens Dumont; Fritz Kauer; Stefan Bohr; Ulrich Schmidtmann; Werner Knopp; Thom πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 191 KB πŸ‘ 1 views

## Abstract This article is about the evaluation of possible differences in biomechanical or histomorphological properties of bone healing between saw osteotomy and random fracturing after 6 months. A standardized, 30Β° oblique monocortical saw osteotomy of sheep tibia was carried out, followed by m

Effect of osteoporosis on bone mineral d
✍ Roseleen M. McCann; Gary Colleary; Carolyn Geddis; Susan A. Clarke; Grant R. Jor πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 263 KB πŸ‘ 2 views

## Abstract Osteoporosis (OP) is one of the most prevalent bone diseases worldwide with bone fracture the major clinical consequence. The effect of OP on fracture repair is disputed and although it might be expected for fracture repair to be delayed in osteoporotic individuals, a definitive answer

The effect of muscle loading on flexor t
✍ Stavros Thomopoulos; Emmanouil Zampiakis; Rosalina Das; Matthew J. Silva; Richar πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 339 KB πŸ‘ 2 views

## Abstract Previous tendon and ligament studies have demonstrated a role for mechanical loading in tissue homeostasis and healing. In uninjured musculoskeletal tissues, increased loading leads to an increase in mechanical properties, whereas decreased loading leads to a decrease in mechanical prop

Effects of short-term Cyclosporin-A on b
✍ Steven B. Warren; Richard R. Pelker; Dr. Gary E. Friedlaender πŸ“‚ Article πŸ“… 1985 πŸ› Elsevier Science 🌐 English βš– 497 KB πŸ‘ 2 views

Cyclosporin-A is a new immunosuppressant drug being used widely for solid organ transplantation. The systemic effects of Cyclosporin-A on the skeletal system have not previously been defined. This study examined the effects of Cyclosporin-A on biomechanical properties of intact bone and fracture rep

The effect of alendronate (Fosamax?) and
✍ Frenkel, Sally R. ;Jaffe, William L. ;Valle, Craig Della ;Jazrawi, Laith ;Maurer πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 1 views

## Abstract Patients at high risk for osteoporosis and its associated morbidity, including postmenopausal women, are being pharmacologically managed to stabilize and improve bone mass. Alendronate sodium (Fosamaxβ„’) is a commonly used antiresorptive agent effective in osteopenic women for reducing b

A randomized two-year study of the effec
✍ Arja HΓ€kkinen; Tuulikki Sokka; Antero Kotaniemi; Pekka Hannonen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

## Objective: To evaluate the impact of a 2-year program of strength training on muscle strength, bone mineral density (bmd), physical function, joint damage, and disease activity in patients with recent-onset (<2 years) rheumatoid arthritis (ra). ## Methods: In this prospective trial, 70 ra pati